BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PPP2R1A, PR65A, 5518, ENSG00000105568, MGC786, P30153
8 results:

  • 1. Outcome of primary androgen deprivation therapy in super-elderly men with localized high-risk prostate cancer.
    Yamamoto Y; Akashi Y; Kiba K; Hirayama A; Uemura H
    Anticancer Drugs; 2022 Jul; 33(6):534-538. PubMed ID: 35276692
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Influence of Geography on prostate cancer Treatment.
    Tang C; Lei X; Smith GL; Pan HY; Hoffman KE; Kumar R; Chapin BF; Shih YT; Frank SJ; Smith BD
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1286-1295. PubMed ID: 33316361
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of key genes involved in the pathogenesis of cutaneous melanoma using bioinformatics analysis.
    Chen J; Sun W; Mo N; Chen X; Yang L; Tu S; Zhang S; Liu J
    J Int Med Res; 2020 Jan; 48(1):300060519895867. PubMed ID: 31937175
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of the Key MicroRNAs and the miRNA-mRNA Regulatory Pathways in prostate cancer by Bioinformatics Methods.
    Li D; Hao X; Song Y
    Biomed Res Int; 2018; 2018():6204128. PubMed ID: 30027097
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Therapeutic relevance of the protein phosphatase 2A in cancer.
    Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ
    Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Proteomic-based identification of multiple pathways underlying n-butylidenephthalide-induced apoptosis in LNCaP human prostate cancer cells.
    Pang CY; Chiu SC; Harn HJ; Zhai WJ; Lin SZ; Yang HH
    Food Chem Toxicol; 2013 Sep; 59():281-8. PubMed ID: 23770345
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.
    Bluemn EG; Spencer ES; Mecham B; Gordon RR; Coleman I; Lewinshtein D; Mostaghel E; Zhang X; Annis J; Grandori C; Porter C; Nelson PS
    Mol Cancer Res; 2013 Jun; 11(6):568-78. PubMed ID: 23493267
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines.
    Teiten MH; Gaigneaux A; Chateauvieux S; Billing AM; Planchon S; Fack F; Renaut J; Mack F; Muller CP; Dicato M; Diederich M
    OMICS; 2012 Jun; 16(6):289-300. PubMed ID: 22475723
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.